Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-3749
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWieser, Simon-
dc.contributor.authorRiguzzi, Marco-
dc.contributor.authorPletscher, Mark-
dc.contributor.authorHuber, Carola A.-
dc.contributor.authorTelser, Harry-
dc.contributor.authorSchwenkglenks, Matthias-
dc.date.accessioned2018-06-18T09:01:43Z-
dc.date.available2018-06-18T09:01:43Z-
dc.date.issued2018-
dc.identifier.issn1618-7601de_CH
dc.identifier.issn1618-7598de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/7015-
dc.description.abstractIn most countries, surprisingly little is known on how national healthcare spending is distributed across diseases. Single-disease cost-of-illness studies cover only a few of the diseases affecting a population and in some cases lead to untenably large estimates. The objective of this study was to decompose healthcare spending in 2011, according to Swiss National Health Accounts, into 21 collectively exhaustive and mutually exclusive major disease categories. Diseases were classified following the Global Burden of Disease Study. We first assigned the expenditures directly mapping from National Health Accounts to the 21 diseases. The remaining expenditures were assigned based on diagnostic codes and clues contained in a variety of microdata sources. Expenditures were dominated by non-communicable diseases with a share of 79.4%. Cardiovascular diseases stood out with 15.6% of total spending, followed by musculoskeletal disorders (13.4%), and mental and substance use disorders (10.6%). Neoplasms (6.0% of the total) ranked only sixth, although they are the leading cause of premature death in Switzerland. These results may be useful for the design of health policies, as they illustrate how healthcare spending is influenced by the epidemiological transition and increasing life expectancy. They also provide a plausibility check for single cost-of-illness studies. Our study may serve as a starting point for further research on the drivers of the constant growth of healthcare spending.de_CH
dc.language.isoende_CH
dc.publisherSpringerde_CH
dc.relation.ispartofThe European Journal of Health Economicsde_CH
dc.rightshttp://creativecommons.org/licenses/by/4.0/de_CH
dc.subjectCost-of-illnessde_CH
dc.subjectDecomposition by diseasede_CH
dc.subjectHealthcare costde_CH
dc.subjectHealthcare expenditurede_CH
dc.subjectNational health accountde_CH
dc.subjectSwitzerlandde_CH
dc.subject.ddc362.1041: Gesundheitsökonomiede_CH
dc.titleHow much does the treatment of each major disease cost? A decomposition of Swiss National Health Accountsde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementSchool of Management and Lawde_CH
zhaw.organisationalunitWinterthurer Institut für Gesundheitsökonomie (WIG)de_CH
dc.identifier.doi10.21256/zhaw-3749-
dc.identifier.doi10.1007/s10198-018-0963-5de_CH
dc.identifier.pmid29470673de_CH
zhaw.funding.euNode_CH
zhaw.issue8de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.end13de_CH
zhaw.pages.end1161de_CH
zhaw.pages.start1de_CH
zhaw.pages.start1149de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume19de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
Appears in collections:Publikationen School of Management and Law

Files in This Item:
File Description SizeFormat 
10.1007_s10198-018-0963-5.pdf1.2 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.